Voyager Therapeutics, Inc.
AADC polynucleotides for the treatment of Parkinson's disease
Last updated:
Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.
Status:
Grant
Type:
Utility
Filling date:
14 Aug 2019
Issue date:
8 Jun 2021